Lipoplex formulations for specific delivery to vascular endothelium

Details for Australian Patent Application No. 2007241370 (hide)

Owner Silence Therapeutics AG.

Inventors Santel, Ansgar; Kaufmann, Jorg; Keil, Oliver

Agent Pizzeys

Pub. Number AU-A-2007241370

PCT Pub. Number WO2007/121947

Priority 06008209.6 20.04.06 EP

Filing date 20 April 2007

Wipo publication date 1 November 2007

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/121947 Priority application(s): WO2007/121947

4 December 2008 Amendment Made

  The nature of the amendment is: Amend the co-inventor name to read Kaufmann, Joerg

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007241378-Polymeric masticatory masses for cosmetic products

2007241369-Means for inhibiting the expression of CD31